NCT05719363Completed
Portable Oxygen Concentrator in Non-hospitalized Patients With Chronic Heart Failure
Portable Oxygen Concentrator in Non-hospitalized Patients With Chronic Heart Failure: A Proof-of-concept Pilot Study
Source: ClinicalTrials.gov · Last updated 3 Jan 2024
Brief summary (registry, in English)
This is a one-day, proof-of-concept, pilot study of portable oxygen concentrator (POC) administration and Six Minute Walk Test (6MWT) distance in patients with stable chronic heart failure.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 25 Jan 2023
- Start date
- 11 Oct 2023
- Primary completion date
- 21 Nov 2023
- Lead sponsor
- Inogen Inc.
- Diseases
- Heart failure
- NCT number
- NCT05719363
What you commit to
- Study type: Interventional
- Participants enrolled: 20
- From 11 Oct 2023 to the primary completion date, 21 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current acute decompensated HF requiring augmented therapy with vasodilator agents, and/or inotropic drugs, and/or augmented therapy or i.v. therapy with diuretics
- History of acute coronary syndrome (unstable angina or myocardial infarction) within 3 months prior to study enrollment
Other
- Contraindication to the use of POC
- Patient currently hospitalized or requiring hospitalization
- Patient unable to walk
- Patient who should be excluded in the opinion of the investigator
- Participation in another interventional clinical trial within 30 days of signing the Information and Consent Form (ICF)
- Pregnant female patient
Who the study is looking for
- Adult male or female
- Diagnosed with chronic stable heart failure
- NYHA functional class II to ambulatory class IV
- Peripheral oxygen saturation on fingertip pulse oximetry (SpO2) ≤96% at rest
- Willingness and ability to use a POC and with no allergy to cannula material
- Patient with the capacity to provide informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Montreal Heart Institute Coordinator of this site? Confirm its status | Montreal | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.